These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7828380)

  • 1. Pharmacokinetics and pharmacodynamics of the diuretic bumetanide in the elderly.
    Oberbauer R; Krivanek P; Turnheim K
    Clin Pharmacol Ther; 1995 Jan; 57(1):42-51. PubMed ID: 7828380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the variability in the pharmacokinetics and pharmacodynamics of bumetanide in critically ill infants.
    Sullivan JE; Witte MK; Yamashita TS; Myers CM; Blumer JL
    Clin Pharmacol Ther; 1996 Oct; 60(4):414-23. PubMed ID: 8873689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog.
    Cohen MR; Hinsch E; Vergona R; Ryan J; Kolis SJ; Schwartz MA
    J Pharmacol Exp Ther; 1976 Jun; 197(3):697-702. PubMed ID: 932999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of bumetanide in critically ill infants.
    Sullivan JE; Witte MK; Yamashita TS; Myers CM; Blumer JL
    Clin Pharmacol Ther; 1996 Oct; 60(4):405-13. PubMed ID: 8873688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of intravenous bumetanide in mutant Nagase analbuminemic rats: importance of globulin binding for the pharmacodynamic effects.
    Kim EJ; Lee MG
    Biopharm Drug Dispos; 2001 May; 22(4):147-56. PubMed ID: 11745917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants.
    Sullivan JE; Witte MK; Yamashita TS; Myers CM; Blumer JL
    Clin Pharmacol Ther; 1996 Oct; 60(4):424-34. PubMed ID: 8873690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bumetanide, a new diuretic active during chronic renal failure (author's transl)].
    Fries D; Beroniade V; Coy JL; Delavelle F
    Pathol Biol (Paris); 1976 Jun; 24(6):435-9. PubMed ID: 785349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of protein and calorie malnutrition on the pharmacokinetics and pharmacodynamics of bumetanide in rats.
    Kim SH; Lee MG
    J Pharm Sci; 1993 Aug; 82(8):838-43. PubMed ID: 8377124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age on the pharmacokinetics of ciprofloxacin.
    Nilsson-Ehle I; Ljungberg B
    Scand J Infect Dis Suppl; 1989; 60():23-7. PubMed ID: 2756350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients.
    Caspi D; Lubart E; Graff E; Habot B; Yaron M; Segal R
    Arthritis Rheum; 2000 Jan; 43(1):103-8. PubMed ID: 10643705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of probenecid on the dose-response relationship of bumetanide at steady state.
    Lau HS; Shih LJ; Smith DE
    J Pharmacol Exp Ther; 1983 Oct; 227(1):51-4. PubMed ID: 6620171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics and pharmacodynamics of the diuretic bumetanide in hepatic and renal disease.
    Marcantonio LA; Auld WH; Murdoch WR; Purohit R; Skellern GG; Howes CA
    Br J Clin Pharmacol; 1983 Feb; 15(2):245-52. PubMed ID: 6849758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients.
    Marshall JD; Wells TG; Letzig L; Kearns GL
    J Clin Pharmacol; 1998 Nov; 38(11):994-1002. PubMed ID: 9824779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of bumetanide.
    Ryoo SH; Lee MG; Lee MH
    Biopharm Drug Dispos; 1993 Apr; 14(3):245-55. PubMed ID: 8490111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of KW-4679 in the elderly: single-dose and multiple-dose trials.
    Tateishi T; Kobayashi S; Shigeyama C; Nakamura T; Kobayashi H
    Drugs Exp Clin Res; 1998; 24(1):1-7. PubMed ID: 9604143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of rifampin administration on the disposition of fexofenadine.
    Hamman MA; Bruce MA; Haehner-Daniels BD; Hall SD
    Clin Pharmacol Ther; 2001 Mar; 69(3):114-21. PubMed ID: 11240975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with extracorporeal membrane oxygenation.
    Wells TG; Fasules JW; Taylor BJ; Kearns GL
    J Pediatr; 1992 Dec; 121(6):974-80. PubMed ID: 1447670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit.
    Pichette V; Geadah D; du Souich P
    Drug Metab Dispos; 1999 Jan; 27(1):81-5. PubMed ID: 9884313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metolazone pharmacokinetics and pharmacodynamics in renal transplantation.
    Gehr TW; Sica DA; Brater DC; Wallace HJ; Davis J; Fakhry I
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):116-23. PubMed ID: 2071258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.